摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl N-(2-pyrazol-1-yl)ethyliminodiacetate | 186667-01-6

中文名称
——
中文别名
——
英文名称
methyl N-(2-pyrazol-1-yl)ethyliminodiacetate
英文别名
methyl N-[2-(1-pyrazolyl)ethyl]iminodiacetate;Methyl 2-[(2-methoxy-2-oxoethyl)-(2-pyrazol-1-ylethyl)amino]acetate
methyl N-(2-pyrazol-1-yl)ethyliminodiacetate化学式
CAS
186667-01-6
化学式
C11H17N3O4
mdl
MFCD18046262
分子量
255.274
InChiKey
UWXNQORGCIYEML-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    18
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.545
  • 拓扑面积:
    73.7
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    methyl N-(2-pyrazol-1-yl)ethyliminodiacetatesodium hydroxide 作用下, 反应 24.0h, 生成 N-(2-pyrazol-1-yl)ethyliminodiacetic acid sodium salt
    参考文献:
    名称:
    N-2-(Azol-1(2)-yl)ethyliminodiacetic acids: a novel series of Gd(III) chelators as T2 relaxation agents for magnetic resonance imaging
    摘要:
    The synthesis, physicochemical properties, and toxicological implications of a novel series of N-2-(azol-1(2)-yl)ethyliminodiacetic acids, useful as contrast agents for magnetic resonance imaging are reported. Compounds were prepared by alkylation of methyl iminodiacetate with N-2-bromoethylazoles and subsequent hydrolysis. Stability constants of the corresponding Gd(III) complexes and T-1 and T-2 relaxivities were determined and interpreted in terms of optimized geometries obtained by semiempirical PM3 calculations. Compounds show increased T-2 relaxivity and decreased toxicity in vitro as compared to EDTA-Gd(III) complexes. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(98)00273-9
  • 作为产物:
    描述:
    亚氨基二乙酸二甲酯1-(2-溴乙基)-1H-吡唑 反应 2.5h, 以55%的产率得到methyl N-(2-pyrazol-1-yl)ethyliminodiacetate
    参考文献:
    名称:
    N-2-(Azol-1(2)-yl)ethyliminodiacetic acids: a novel series of Gd(III) chelators as T2 relaxation agents for magnetic resonance imaging
    摘要:
    The synthesis, physicochemical properties, and toxicological implications of a novel series of N-2-(azol-1(2)-yl)ethyliminodiacetic acids, useful as contrast agents for magnetic resonance imaging are reported. Compounds were prepared by alkylation of methyl iminodiacetate with N-2-bromoethylazoles and subsequent hydrolysis. Stability constants of the corresponding Gd(III) complexes and T-1 and T-2 relaxivities were determined and interpreted in terms of optimized geometries obtained by semiempirical PM3 calculations. Compounds show increased T-2 relaxivity and decreased toxicity in vitro as compared to EDTA-Gd(III) complexes. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(98)00273-9
点击查看最新优质反应信息

文献信息

  • COMPLEXONES WITH THE STRUCTURE OF N-2-(AZOL-1(2)-YL)ETHYLIMINODIACETIC ACIDS, SYNTHESIS, ANALYTICAL STUDY AND BIOLOGICAL APPLICATIONS
    申请人:UNIVERSIDAD NACIONAL DE EDUCACION A DISTANCIA
    公开号:EP0790241A1
    公开(公告)日:1997-08-20
    Complexones having the structure of N-2-(azol-1(2)-yl(ethyl-iminodiacetic acids, synthesis, analytical study and biological applications, characterized by their complexing capacity over Ca2+, Mg2+ ions and other bivalent cations, lanthanides and transition metals. In the formula azolN-CH2-CH2-N(CH2-CO2R)2 (I), azol is pirazol; 3,5-dimethylpirazol; indazol; etc. and R is alkyl or H or Na. The compounds having the general formula (I), are obtained by an alkylation reaction of methyl iminodiacetate with N-bromoethylazols and further hydrolysis in acid or basic medium. The process may be modified by alternative synthetic processes which involve N-aminoethylazols as starting materials or the use of cyclization processes in the preparation of N-substituted azol. They can be applied in spectroscopy and nuclear magnetic resonance (NMR) imaging of hydrogen or other nuclei as extrinsic probes of Ca2+, Mg2+ or other metal ions and as contrast agents, in solutions, biological extracts, tissues, entire animals and human beings.
    具有 N-2-(azol-1(2)-yl(ethyl-iminodiacetic acids)结构的络合剂的合成、分析研究和生物应用,其特点是对 Ca2+、Mg2+ 离子和其他二价阳离子、镧系元素和过渡金属的络合能力。在式 azolN-CH2-CH2-N(CH2-CO2R)2 (I) 中,azol 是吡唑;3,5-二甲基吡唑;吲唑等,R 是烷基或 H 或 Na。具有通式(I)的化合物是通过亚氨基二乙酸甲酯与 N-溴乙基唑的烷基化反应,并在酸性或碱性介质中进一步水解得到的。该工艺可通过其他合成工艺进行改良,如将 N-氨基乙基偶氮酚作为起始原料,或在制备 N-取代偶氮酚时使用环化工艺。它们可作为 Ca2+、Mg2+ 或其他金属离子的外在探针和造影剂,应用于溶液、生物提取物、组织、整个动物和人体中氢或其他核的光谱学和核磁共振(NMR)成像。
  • N-2-(Azol-1(2)-yl)ethyliminodiacetic acids: a novel series of Gd(III) chelators as T2 relaxation agents for magnetic resonance imaging
    作者:Pilar López、Christa G Seipelt、Patrick Merkling、Laszlo Sturz、José Álvarez、Andreas Dölle、Manfred D Zeidler、Sebastián Cerdán、Paloma Ballesteros
    DOI:10.1016/s0968-0896(98)00273-9
    日期:1999.3
    The synthesis, physicochemical properties, and toxicological implications of a novel series of N-2-(azol-1(2)-yl)ethyliminodiacetic acids, useful as contrast agents for magnetic resonance imaging are reported. Compounds were prepared by alkylation of methyl iminodiacetate with N-2-bromoethylazoles and subsequent hydrolysis. Stability constants of the corresponding Gd(III) complexes and T-1 and T-2 relaxivities were determined and interpreted in terms of optimized geometries obtained by semiempirical PM3 calculations. Compounds show increased T-2 relaxivity and decreased toxicity in vitro as compared to EDTA-Gd(III) complexes. (C) 1999 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物